Low / normal result
- Heart failure is much less likely as the cause of breathlessness
- BNP below 100 pg/mL or NT-proBNP below 300 pg/mL (any age)
- Reassuring - look for other reasons for symptoms
- Exception: in obesity, a low level may still miss HF
Names & Terms You Will Hear
Plain-language meanings for the terms your care team may use.
| Term | Meaning |
|---|---|
| BNP (B-type natriuretic peptide) | A hormone your heart muscle makes and releases into the blood when its walls are stretched or under strain. A blood test measures how much is present. |
| NT-proBNP (N-terminal pro-BNP) | A related piece released at the same time as BNP. It tells the same story but stays in the blood longer and is not affected by Entresto. The two are measured on different scales and cannot be compared directly. |
| Natriuretic peptide | The family name for both BNP and NT-proBNP. These hormones help the body let go of salt and water to ease the load when the heart is strained. |
| Heart failure (HF) | When the heart cannot pump or fill as well as it should. It is the most common reason these hormones run high. A low level makes heart failure much less likely as the cause of breathlessness. |
| Rule-out value | A level low enough to make a diagnosis unlikely. For heart failure in a breathless patient, a low BNP or NT-proBNP is a strong signal that the heart is not the main problem. |
| Age-stratified threshold | NT-proBNP cut-points that shift with age. Older people naturally have higher levels, so the number used to call a result 'high' is different at 40 than at 80. |
| Confounder | Something that pushes the level up or down apart from heart strain. Common ones: older age, kidney disease, atrial fibrillation, obesity, and a medicine called sacubitril (Entresto). |
| Sacubitril / Entresto | A heart-failure medicine that blocks the enzyme that breaks down BNP. Patients on Entresto can have a high measured BNP even when the heart is doing better. NT-proBNP is used instead to monitor these patients. |
| Gray zone | A result that is not clearly low (reassuring) or clearly high (pointing to strain). In the gray zone, the level is read alongside symptoms, exam, and an echo to make sense of it. |
| Serial testing / trending | Checking the level more than once over time. A falling level usually means treatment is working; a rising level is an early warning to look again. |
The most important thing to know about this test. A LOW BNP or NT-proBNP is one of the strongest rule-outs in cardiology: it makes heart failure much less likely as the cause of breathlessness. A HIGH level is a clue to heart strain - but age, kidney function, atrial fibrillation, and body weight all shift the number. Always read the result alongside your symptoms, your exam, and an echo.
What Is Your BNP / NT-proBNP Blood Test?
- BNP and NT-proBNP are hormones made by the heart's lower chambers. When those walls are stretched by pressure or extra fluid, the muscle releases more into the blood.
- A blood test measures how much is present. BNP and NT-proBNP run on different scales. A BNP value and an NT-proBNP value cannot be compared directly.
- A low level is reassuring. It makes heart failure much less likely as the cause of breathlessness. This is called a 'rule-out' value - one of the most useful features of the test.
- A high level is a clue to heart strain - most often heart failure. But the number is not a diagnosis by itself. Other things raise it, and body weight can lower it.
- One key point about Entresto (sacubitril/valsartan): this heart-failure medicine blocks the enzyme that breaks down BNP. So BNP rises in the blood even when the heart is doing better. NT-proBNP is not affected and is used instead in these patients.
A Low or Normal Result: Heart Failure Is Unlikely
- A low result is a powerful rule-out. A BNP below 100 pg/mL or an NT-proBNP below 300 pg/mL makes heart failure much less likely as the cause of breathlessness. This is one of the strongest rule-out tests in cardiology.
- The accuracy is high. Large studies found that a low level rules out heart failure more than 90% of the time in breathless emergency patients.
- A low result does not explain the breathlessness - it redirects the search. The symptom still needs an answer: a lung problem, anemia, deconditioning, or another cause.
- Obesity caveat: people who carry more weight tend to have lower levels for the same heart strain. A 'normal' level in a heavier patient with symptoms is not as reassuring.
- HFpEF caveat: stiff-heart failure (HFpEF) often shows a lower or less elevated level than weak-pump failure (HFrEF). A borderline result does not rule out HFpEF.
- Takeaway: a low result is strongly reassuring but is always read with the whole picture.
How to Read Your Result
Gray zone result
- Not clearly low (reassuring) or clearly high (pointing to strain)
- May reflect mild strain, age, kidney function, or early HF
- Read carefully with symptoms, exam, and body weight
- Usual next step: an echo and a recheck
High result
- Points toward heart strain - most likely heart failure
- Still check confounders: kidney function, AFib, lungs
- NT-proBNP above age-adjusted cut-point is significant
- Usual next step: echo, focused workup, start treatment
Why It Matters
- A low value is a strong reassurance. When breathlessness is the concern, a low BNP or NT-proBNP makes heart failure an unlikely cause. Your doctor can look confidently for other reasons.
- A high value is often the first clear sign that the heart is under strain - sometimes before the cause is obvious. Finding it early means the right tests start sooner.
- The test is also fast. One blood draw can guide next steps quickly: does this person need an echo today, or is heart failure less likely?
- Confounders matter too. Older age, kidney disease, and atrial fibrillation all raise the level even when the heart pump is not the main problem. Reading the number without context can send the workup the wrong way.
- Body weight is a key caveat. People with higher body weight tend to have lower levels for the same heart strain. A 'normal' result in a heavier patient can be falsely reassuring.
- If you are on Entresto, your lab may show a high BNP. This is expected. NT-proBNP is used instead to follow how the heart is doing on this medicine.
What Moves BNP / NT-proBNP - and Which Direction
| Factor | Effect on level | Clinical implication |
|---|---|---|
| Heart failure / heart strain | Raises it (most) | Primary target - the cause we most want to find |
| Older age | Raises it | Age-adjusted thresholds account for this |
| Kidney disease (CKD) | Raises it | NT-proBNP rises more; read alongside kidney labs |
| Atrial fibrillation (AFib) | Raises it | AFib alone raises it; sort with echo and rhythm check |
| Lung clot / serious illness | Raises it | Acute non-cardiac stress raises it - read with the story |
| Female sex | Raises it slightly | Women tend to run slightly higher - lab norms reflect this |
| Obesity / higher body weight | Lowers it | Can mask real HF - a 'normal' in obesity needs extra care |
| Entresto (sacubitril) | Raises BNP only | Use NT-proBNP to monitor HF patients on Entresto |
A High Result: Heart Strain Likely - Read with Context
- A high level points toward heart strain - most often heart failure. It is a reason to look closer, usually with an echo and a careful exam.
- Age cut-points matter. A level ABOVE these NT-proBNP cutoffs points to heart failure: above 450 pg/mL for people under 50, above 900 for ages 50 to 75, above 1800 for people over 75. Older bodies naturally make more of these hormones, so the cutoff rises with age.
- A high level is not a diagnosis. Other things raise it: kidney disease, atrial fibrillation, a lung clot, serious infection, and older age. The workup sorts the real cause.
- The gray zone (between rule-out and rule-in cut-points) is common. The echo and the clinical picture resolve it.
- A mildly high level may reflect early HF, age, or kidney function. A very high level is a stronger signal of strain. Both deserve follow-up.
- Takeaway: a high result starts the workup - an echo, a kidney check, a rhythm check. It does not name the diagnosis.
Want to understand your BNP or NT-proBNP number? Try our Understand Your Result tool. Pick your test, type in your value, and see which general range it falls in. It is a learning tool only, not a diagnosis. Always go over your result with your doctor.
Risk Factors
Knowing your personal risks helps your care team take extra precautions.
| Risk Factor | Why It Increases Risk |
|---|---|
| Heart failure / heart strain | The main reason the level rises. A weak pump (HFrEF) or a stiff heart (HFpEF) both stretch the ventricular walls and push the level up. The more strain, the higher the number tends to run. |
| Older age | The level rises naturally with age. An older person can have a higher 'normal' than a younger one. Age-stratified NT-proBNP thresholds adjust for this. |
| Kidney disease (CKD) | The kidneys clear these hormones from the blood. When the kidneys work less well, the level rises - sometimes even without extra heart strain. NT-proBNP rises more than BNP with worsening kidney function. |
| Atrial fibrillation (AFib) | This common irregular heart rhythm raises the level on its own, separate from pump problems. A high result in someone with AFib needs to be read with extra care. |
| Pulmonary embolism / serious illness | A clot in the lungs, severe infection, major surgery, or other critical illness can raise the level by putting sudden strain on the heart and body. |
| Higher body weight - LOWERS the level | Obesity is the opposite confounder. People who carry more weight have lower levels for the same amount of heart strain. A 'normal' number in a heavier patient with symptoms may not be as reassuring as it looks. |
| Sacubitril / Entresto - RAISES BNP only | This heart-failure medicine blocks the enzyme that breaks down BNP, so measured BNP rises while the heart may actually be improving. NT-proBNP is not affected and is used instead in these patients. |
The Obesity and HFpEF Caveat: When the Level Looks Falsely Low
- Obesity lowers BNP and NT-proBNP. People with a body mass index above 30 have lower levels for the same heart strain compared to lean patients. This is a well-known and clinically important finding.
- This matters most for rule-out. A 'normal' level in a patient with obesity and breathlessness should not be taken as strong reassurance. The same cutoff may miss real HF in a heavier person.
- HFpEF (stiff-heart failure) often shows a lower or less elevated level than HFrEF (weak-pump failure). Many HFpEF patients have both obesity and stiff hearts. The level can fall in the gray zone even with active heart failure.
- In these patients, the echo findings, the symptoms, and exercise response carry extra weight. The peptide level is one data point, not the deciding number.
- Takeaway: obesity and HFpEF are the two settings where a 'normal-looking' level is least reassuring. Ask your doctor which thresholds apply to you.
Treatment Options
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
- The test itself is simple: a single blood draw. No fasting or special prep is needed.
- If the result is low: heart failure is unlikely as the cause of breathlessness. Your doctor will look for other reasons - lung, anemia, or fitness - without an urgent echo in most cases.
- If the result is high or in the gray zone: the usual next step is an echocardiogram (echo). This ultrasound shows the pump strength and stiffness of the heart walls directly.
- A high result also prompts a check of confounders: kidney function, heart rhythm (for AFib), and - when the story fits - the lungs. Sorting the cause is the point.
- If heart failure is found, treatment is aimed at it. The number itself is not treated. As heart failure improves, the level usually falls on its own.
- If you are on Entresto: your team uses NT-proBNP to track the heart. A high BNP on Entresto does not mean the medicine is not working.
- Checking the level over time helps steer care. A falling level means treatment is working. A rising level is a prompt to look again - often before symptoms return.
Trending the Number Over Time
- One reading is a snapshot. A series of readings over time shows the trend. In managed heart failure, the trend often tells more than any single value.
- A falling level usually means the extra fluid is coming off and the strain is easing. This is the direction we want to see.
- A rising level - even before symptoms return - is an early warning. Catching it at a clinic visit lets us adjust medicines before a full flare.
- The goal level varies by person. A lower, stable level on treatment is the aim. The level at which you feel your best becomes your personal benchmark.
- Not everyone needs frequent rechecks. Your doctor decides how often based on how stable you are.
- For more on what a high result means and what happens next: High BNP or NT-proBNP Result | HFrEF (weak pump) | HFpEF (stiff heart) | Echo guide | Diuretics guide.
Entresto note. Sacubitril/valsartan (Entresto) blocks the enzyme that breaks down BNP, so BNP rises in the blood even when the heart is improving. If you are on Entresto and see a HIGH BNP on your lab report, do not be alarmed and do not stop the medicine. Your care team uses NT-proBNP instead to track how the heart is doing on this medicine.
Risks, Benefits, and Alternatives
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.
| Option | Risks | Benefits | Alternatives |
|---|---|---|---|
| Getting tested when breathless vs. waiting | One blood draw and a brief wait. The test is safe and almost painless. | A low result can quickly and confidently rule heart failure out - often saving a more involved workup. A high result starts the right path faster. | If symptoms are mild and the story is not urgent, the test can be planned at an office visit rather than the emergency department. |
| Acting on a high result (echo + workup) vs. ignoring it | An echo and a focused workup mean a few more tests and some extra time. These are safe, non-invasive steps. | Following a high level to its cause - heart failure, kidney disease, AFib, a lung clot - opens the door to treatment early, before a flare. | If the level is mildly high and you feel well, the workup may be as simple as an echo and a recheck - not an exhaustive search. |
| Tracking the level over time vs. a single snapshot | Repeat blood draws mean a small extra step at follow-up visits. | The trend often tells more than one reading. A falling level confirms treatment is working; a rising one can catch fluid build-up before symptoms return. | Not everyone needs frequent rechecks. Your doctor decides how often based on your diagnosis and how stable you are. |
Common Misconceptions
| Myth | Reality |
|---|---|
| A high BNP or NT-proBNP means I have heart failure. | Not by itself. A high level supports heart failure when symptoms and exam fit, but older age, kidney disease, AFib, and a lung clot also raise it. An echo and a careful exam confirm the cause. |
| A normal level means my heart is definitely fine. | Usually reassuring - but not always. People with higher body weight tend to have lower levels for the same heart strain. A 'normal' result in someone with obesity and breathlessness still deserves a look. |
| BNP and NT-proBNP are the same test on the same scale. | They carry the same message but run on different scales. A BNP of 200 and an NT-proBNP of 200 are not the same finding. Your lab reports one or the other, and your doctor uses the right cutoff for whichever was run. |
| My BNP went up because I started Entresto - the medicine is not working. | The opposite is likely true. Entresto blocks the enzyme that breaks down BNP, so BNP rises while the heart may be improving. NT-proBNP is used instead to track the heart on this medicine. Do not stop Entresto because of a high BNP without talking to your doctor. |
| A high result means I need a heart procedure. | Usually not. Most high results lead to medicines and an echo - not a procedure. A procedure is only considered if the underlying cause calls for one, such as a valve problem or a blockage. |
| The number itself needs to be 'treated'. | We treat the cause, not the number. As heart failure or another trigger improves, the level usually falls on its own. |
| A low level means I can ignore breathlessness. | A low level makes heart failure less likely - but the breathlessness still needs an explanation. Lungs, anemia, fitness, or another cause may be responsible. A low result redirects the search, not ends it. |
Possible Complications
Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.
| Where / What | What Can Happen |
|---|---|
| Falsely low result in obesity masking real heart failure | People who carry more weight have lower BNP and NT-proBNP for the same amount of heart strain. A 'normal' level can hide real heart failure in a heavier patient. This is why the test is always read alongside symptoms, body weight, and an echo - not in isolation. |
| Falsely high result from a non-cardiac confounder | Kidney disease, older age, AFib, a lung clot, or serious illness can raise the level even when the heart pump is not the main problem. Acting on the number without sorting the cause can lead to the wrong tests and unnecessary worry. |
| Missing HFpEF (stiff-heart heart failure) because the level is less elevated | Heart failure with a preserved ejection fraction (HFpEF) - where the heart pump strength is normal but the walls are stiff - often shows a lower or less-elevated natriuretic peptide level than HFrEF. A 'not very high' result does not rule out HFpEF. |
| Confusion about Entresto and a high BNP | Patients on Entresto who see a high BNP on their lab report may worry that the medicine is not working. The opposite is often true. Stopping or changing the medicine because of this misread can worsen outcomes. |
| Anxiety from a high result with no clear plan | A high number with no follow-up visit scheduled is stressful. The fastest remedy is a clear next step - an echo, an office visit, a recheck date. If a result arrives without a plan, call the office and ask. |
Points to Know
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you remember nothing else, remember these key points.
- BNP and NT-proBNP are hormones the heart releases when its walls are stretched. A low level makes heart failure much less likely.
- A high level is a clue to heart strain but is not a diagnosis by itself. Age, kidney function, body weight, and other conditions all affect the number.
- NT-proBNP has a longer half-life and is more affected by kidney disease. BNP is affected by Entresto; NT-proBNP is not - so NT-proBNP is preferred for monitoring patients on Entresto.
- NT-proBNP rules heart failure OUT below 300 pg/mL at any age. It rules heart failure IN above an age-based cutoff that rises with age: above 450 (under 50), above 900 (ages 50-75), above 1800 (over 75).
- In people with higher body weight, both hormones run lower for the same heart strain. A 'normal' result in an obese patient with breathlessness should still be read with care.
- BNP and NT-proBNP are measured on different scales - comparing one number to the other is not valid.
- The trend over time often matters as much as a single reading. A falling level with treatment is reassuring; a rising level is a prompt to look again.
- The test result points the workup - an echo and an exam are what make the diagnosis. The number is never the whole answer.
When to Call Us — and When to Call 911
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you are not sure, call. We would rather hear from you twice than miss a real problem.
- New or worsening shortness of breath - especially at rest, lying flat, or waking you from sleep - call us the same day or call 911 if it is severe. Do not wait.
- New swelling in the legs, ankles, or belly, or a weight gain of 3 or more pounds in 2 days - call us. These can mean fluid is building up.
- Chest pain or pressure lasting more than a few minutes, or coming with sweating, nausea, or pain in the arm or jaw - call 911 and treat it as a possible heart attack.
- Feeling faint, a pounding or irregular heartbeat, or lightheadedness that does not pass quickly - call us the same day, or 911 if severe.
- You received a high result and have not been told what to do next - call us. A clear next step is the fastest cure for a worried week.
- You are on Entresto and see a high BNP on your lab report - call us before changing anything. This is expected and usually not alarming, but your team should confirm.
- Any lab result or word on your report that you do not understand - call us. We are glad to explain.
Office: (727) 943-5200
Trusted Resources
Independent, evidence-based pages we recommend for deeper reading.
- MedlinePlus - BNP Test (NIH/NLM) — US National Library of Medicine plain-language explanation of why the test is ordered, what normal and high results mean, and common confounders.
- Cleveland Clinic - BNP Blood Test — Patient-friendly overview of BNP and NT-proBNP interpretation, including confounders and how the result fits into a heart-failure workup.
- American Heart Association - Diagnosing Heart Failure — AHA overview of how natriuretic peptide testing supports a heart-failure diagnosis alongside echocardiogram and physical exam.
- Mayo Clinic - BNP Test — Authoritative patient overview of the BNP test: what it measures, what the result means, and when the test is ordered.
- NHLBI - Heart Failure — Federal National Heart, Lung, and Blood Institute overview of heart failure - what it is, how it is found, and how it is treated.
- CardioSmart (ACC) - Heart Failure — ACC patient-facing decision aids and explainers for understanding heart-failure testing and follow-up visits.
Sources Used to Build This Guide
- Heidenreich PA et al. 2022 AHA/ACC/HFSA Heart Failure Guideline. Circulation 2022 [guideline] — Guideline role of natriuretic peptides in diagnosis, prognosis, and rule-out of HF; Class I recommendation for BNP/NT-proBNP testing in suspected HF.
- McDonagh TA et al. 2021 ESC Guidelines for Heart Failure. Eur Heart J 2021 [guideline] — ESC guideline NT-proBNP rule-out thresholds and age-stratified cut-points for diagnosis and exclusion of HF.
- Maisel AS et al. Breathing Not Properly (BNP in acute dyspnea). NEJM 2002 [primary-evidence] — Landmark accuracy data: BNP <100 pg/mL had 90% negative predictive value for ruling out HF in ED dyspnea patients.
- Januzzi JL et al. PRIDE study (NT-proBNP, age-stratified cutoffs). Am J Cardiol 2005 [primary-evidence] — Age-stratified NT-proBNP thresholds: <450 pg/mL (under 50), <900 pg/mL (50-75), <1800 pg/mL (over 75) for rule-out; rule-in >=450/<900/<1800.
- Januzzi JL et al. NT-proBNP rule-out of acute HF (ICON study). Am Heart J 2006 [primary-evidence] — Validation of NT-proBNP rule-out threshold <300 pg/mL (96% NPV) across all ages — the universal rule-out value used in guidelines.
- Mehra MR et al. Obesity and natriuretic peptides (falsely low BNP). J Am Coll Cardiol 2004 [primary-evidence] — Key confounder: obese patients can have falsely low BNP despite real HF; levels inversely correlated with BMI independent of cardiac function.
- Packer M et al. Sacubitril/valsartan raises BNP but not NT-proBNP (PARADIGM-HF sub-analysis). JACC 2020 [primary-evidence] — Entresto (sacubitril/valsartan) degrades BNP — labs may see elevated BNP on Entresto; NT-proBNP is the preferred monitoring biomarker during ARNI therapy.
- MedlinePlus — BNP Test (NIH/NLM) [patient-education] — Plain-language patient framing of why the test is ordered, what normal and high values suggest, and what confounders matter.
- Cleveland Clinic — BNP Blood Test [patient-education] — Patient-facing normal vs. high interpretation, confounders, and how the test fits into a heart-failure workup.
- Mayo Clinic — BNP Test overview [patient-education] — Authoritative patient-level framing of BNP vs. NT-proBNP, the rule-out value, and common confounders reviewed for this guide.
- American Heart Association — Understanding Heart Failure Diagnosis [patient-education] — AHA patient-facing overview of how natriuretic peptide testing fits in the heart-failure diagnosis pathway alongside echocardiogram.
